Gatlan Review
Best for: Buyers seeking a named-clinical-leadership GLP-1 platform with Dr. Robert Lufkin (UCLA/USC) as Chief Medical Advisor, who value verifiable academic credentials over anonymous DTC marketplace framing, and who live in one of the 44 covered states. Strong fit for premium-clinical-attention buyers who are comfortable with pricing gated behind sign-up.
Gatlan (gatlan.com) is a 'Doctor-Level Care, Minus the Friction'-positioned telehealth platform offering compounded tirzepatide for weight management. DISTINCTIVE NAMED CLINICAL LEADERSHIP — Chief Medical Advisor: **Dr. Robert Lufkin** (Professor at UCLA/USC School of Medicine) — uncommon transparency vs the DTC market that typically hides clinical leadership. Licensed in 44 US states with explicit enumeration: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington DC, West Virginia, Wisconsin, Wyoming. Brand promise: 'personalized precision care' via 'licensed medical professional' review with '100% online process' and 'concierge delivery & monitoring.' Customer testimonial verbatim: 'their team clearly explained how compounded tirzepatide works.' NOT disclosed publicly: specific pricing tiers, LegitScript ID or certification mention, named 503A/503B pharmacy partner, FDA compounded-medication disclaimer text, refund/cancellation policy, governing law, corporate legal entity (LLC/Inc/PC), corporate physical address. Whether compounded semaglutide is also offered (alongside tirzepatide) is not stated on the homepage. Live-verified 2026-05-19.
High confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Gatlan is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Gatlan prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •**Named Chief Medical Advisor with verifiable credentials** — Dr. Robert Lufkin (UCLA/USC School of Medicine Professor) is genuinely uncommon transparency vs the DTC GLP-1 market where most platforms hide clinical leadership behind 'team of licensed providers' generic framing. Verifiable academic credential.
- •44-state explicit enumeration with named states — buyers can directly confirm coverage for their state without navigating to a sign-up flow
- •'Doctor-Level Care, Minus the Friction' positioning targets buyers who want premium clinical attention vs marketplace-platform feel
- •100% online process with concierge delivery & monitoring framing
- •Tirzepatide compounded confirmed via customer testimonial
✗ Cons
- •Specific pricing NOT disclosed on the public homepage — fully gated behind sign-up flow
- •Whether compounded SEMAGLUTIDE is also offered (alongside tirzepatide) is unclear — only tirzepatide is mentioned in the indexable homepage content
- •LegitScript certification status NOT disclosed
- •Specific 503A/503B pharmacy partner NOT named
- •503A vs 503B compounding designation NOT specified
- •Verbatim FDA compounded-medication disclaimer NOT published on the homepage
- •Corporate legal entity (LLC/Inc/PC) NOT disclosed
- •Corporate physical address NOT disclosed
- •Governing law / arbitration venue NOT disclosed
- •Refund / cancellation policy NOT publicly detailed
- •7 states excluded (AK, AR, MA, NM, OR, RI, SC) — buyers in those states are not eligible
Ready to start with Gatlan?
See current pricing and start your free consultation.
Sources & methodology
Our Gatlan review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Gatlan
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Gatlan?
See current pricing and start your free consultation.